Hope there is enough muscle to give them a kicking. As its played out the AS witch hunt that came to largely nothing and delays in filings which subsequently has limited any offerings appears an orchestrated charade to stop the company from disclosing info in a prospectus to market that would have allowed them to raise money.
With signed bits of paper from Medimmune, Sanofi and Amgen they could have raised cash...but appears the board care more about a position in an Orbimed owned company
UNS Price at posting:
0.5¢ Sentiment: None Disclosure: Not Held
